How glucocorticoid receptors modulate the activity of other transcription factors: A scope beyond tethering

Molecular and Cellular Endocrinology

Volumn 380, Issue 1-2, 2013, Pages 41-54

  Ratman, Dariusz ^a   Vanden Berghe, Wim ^b   Dejager, Lien ^a,c   Libert, Claude ^a,c   Tavernier, Jan ^a   Beck, Ilse M ^d   De Bosscher, Karolien ^a  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Cross talk; Glucocorticoid receptor; Glucocorticoids; Transactivation; Transcription factor; Transrepression

Indexed keywords

DNA; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; MICRORNA 124; MICRORNA 145; MICRORNA 155; NUCLEAR FACTOR I; NUCLEAR RECEPTOR COACTIVATOR 2; OCTAMER TRANSCRIPTION FACTOR; RNA POLYMERASE II; STEROID RECEPTOR COACTIVATOR 1; STEROID RECEPTOR COACTIVATOR 3; TATA BINDING PROTEIN; TATA BINDING PROTEIN ASSOCIATED FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1;

ANTIINFLAMMATORY ACTIVITY; DNA BINDING; DNA RESPONSIVE ELEMENT; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; IMMUNOREGULATION; INFLAMMATION; INHIBITION KINETICS; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; RECEPTOR OCCUPANCY; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSREPRESSION;

ACC1; ACETYL CO(-ENZYME) A CARBOXYLASE 1; ACTIVATION FUNCTION; ACTIVATOR PROTEIN 1; AF; AP-1; BRAHMA-RELATED GENE 1; BRG1; C/EBPΒ; CAMP RESPONSE ELEMENT (CRE) BINDING PROTEIN (CREB)-BINDING PROTEIN; CBP; CCAAT/ENHANCER BINDING PROTEIN Β; CDK; CHIP; CHROMATIN IMMUNOPRECIPITATION; CORTICOTROPIN-RELEASING HORMONE; CRH; CROSS-TALK; CYCLIN-DEPENDENT KINASE; DBD; DEX; DEXAMETHASONE; DHS; DNA-BINDING DOMAIN; DNASE I HYPERSENSITIVE SITES; DUAL-SPECIFICITY PHOSPHATASE 1; DUSP1; ERK; EXTRACELLULAR SIGNAL-REGULATED KINASE; FAS; FATTY ACID SYNTHASE; GBS; GC; GC RESPONSE ELEMENT; GC-INDUCED LEUCINE ZIPPER; GILZ; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR INTERACTING PROTEIN 1; GLUCOCORTICOIDS; GLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE; GPAT; GR; GR BINDING SEQUENCE; GRE; GRIP1; H; HDAC; HEAT SHOCK PROTEIN; HISTONE; HISTONE DEACETYLASE; HOMOLOG OF DROSOPHILA 'MOTHERS AGAINST DECAPENTAPLEGIC'; HSP; IFN; INHIBITOR OF NF-ΚB; INTERFERON; INTERFERON REGULATORY FACTOR; INTERFERON-STIMULATED GENE FACTOR 3; IRF; ISGF3; IΚB; LBD; LIGAND-BINDING DOMAIN; LUC; LUCIFERASE; MAP KINASE KINASE; MAP KINASE PHOSPHATASE 1; MAPK; MINERALOCORTICOID RECEPTOR; MITOGEN- AND STRESS-ACTIVATED PROTEIN KINASE; MITOGEN-ACTIVATED PROTEIN KINASE; MKK; MKP-1; MMTV; MOUSE MAMMARY TUMOR VIRUS; MR; MSK; N-TERMINAL TRANSACTIVATION DOMAIN; NERVE GROWTH FACTOR-INDUCED CLONE B; NF-AT; NF-ΚB; NF1; NGFI-B; NLSS; NTD; NUCLEAR FACTOR 1; NUCLEAR FACTOR OF ACTIVATED T CELL; NUCLEAR FACTOR-ΚB; NUCLEAR LOCALIZATION SEQUENCES; OTF1; PEPCK; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; PHOSPHOENOLPYRUVATE CARBOXYKINASE; PIC; PKA; PKB; POMC; POSITIVE TRANSCRIPTION ELONGATION FACTOR B; PPAR; PRE-INITIATION COMPLEX; PRO-OPIOMELANOCORTIN; PROTEIN KINASE A; PROTEIN KINASE B; PTEFB; RA; REDIRECTED FROM COGNATE TRANSCRIPTION FACTOR OCTAMER 1; RETINOIC ACID; RETINOID X RECEPTOR; RNA POL II; RNA POLYMERASE II; RXR; SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION; SILENCING MEDIATOR OF RETINOIC ACID AND THYROID HORMONE RECEPTORS; SMAD; SMRT; SRC-1; STAT; STEROID RECEPTOR COACTIVATOR 1; TATA-BINDING PROTEIN; TBP; TF; TLR; TNF; TOLL-LIKE RECEPTOR; TRANSACTIVATION; TRANSCRIPTION FACTOR; TRANSREPRESSION; TUMOR NECROSIS FACTOR;

ANIMALS; CHROMATIN; EPIGENETIC REPRESSION; HUMANS; PROTEIN KINASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, GLUCOCORTICOID; RESPONSE ELEMENTS; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 84884535373     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2012.12.014     Document Type: Review

References (169)

1. Adams M., Meijer O.C., Wang J., Bhargava A., Pearce D. Homodimerization of the glucocorticoid receptor is not essential for response element binding: activation of the phenylethanolamine N-methyltransferase gene by dimerization-defective mutants. Mol. Endocrinol. 2003, 17:2583-2592.
2. Adcock I.M., Caramori G., Chung K.F. New targets for drug development in asthma. Lancet 2008, 372:1073-1087.
3. Bain D.L., Yang Q., Connaghan K.D., Robblee J.P., Miura M.T., Degala G.D., Lambert J.R., Maluf N.K. Glucocorticoid receptor-DNA interactions: binding energetics are the primary determinant of sequence-specific transcriptional activity. J. Mol. Biol. 2012, 422:18-32.
4. Barboric M., Nissen R.M., Kanazawa S., Jabrane-Ferrat N., Peterlin B.M. NF-kappaB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II. Mol. Cell 2001, 8:327-337.
5. Barnes P.J., Adcock I.M. Glucocorticoid resistance in inflammatory diseases. Lancet 2009, 373:1905-1917.
6. Baschant U., Frappart L., Rauchhaus U., Bruns L., Reichardt H.M., Kamradt T., Brauer R., Tuckermann J.P. Glucocorticoid therapy of antigen-induced arthritis depends on the dimerized glucocorticoid receptor in T cells. Proc. Natl. Acad. Sci. USA 2011, 108:19317-19322.
7. Beck I.M., Vanden Berghe W., Vermeulen L., Bougarne N., Vander Cruyssen B., Haegeman G., De Bosscher K. Altered subcellular distribution of MSK1 induced by glucocorticoids contributes to NF-kappaB inhibition. EMBO J. 2008, 27:1682-1693.
8. Beck I.M., Vanden Berghe W., Vermeulen L., Yamamoto K.R., Haegeman G., De Bosscher K. Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases. Endocr. Rev. 2009, 30:830-882.
9. Beck I.M., De Bosscher K., Haegeman G. Glucocorticoid receptor mutants: man-made tools for functional research. Trends Endocrinol. Metab. 2011, 22:295-310.
10. Belvisi M.G., Wicks S.L., Battram C.H., Bottoms S.E., Redford J.E., Woodman P., Brown T.J., Webber S.E., Foster M.L. Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activity. J. Immunol. 2001, 166:1975-1982.
11. Bhandare R., Damera G., Banerjee A., Flammer J.R., Keslacy S., Rogatsky I., Panettieri R.A., Amrani Y., Tliba O. Glucocorticoid receptor interacting protein-1 restores glucocorticoid responsiveness in steroid-resistant airway structural cells. Am. J. Respir. Cell Mol. Biol. 2010, 42:9-15.
12. Bhatt D.M., Pandya-Jones A., Tong A.J., Barozzi I., Lissner M.M., Natoli G., Black D.L., Smale S.T. Transcript dynamics of proinflammatory genes revealed by sequence analysis of subcellular RNA fractions. Cell 2012, 150:279-290.
13. Biddie S.C., John S., Hager G.L. Genome-wide mechanisms of nuclear receptor action. Trends Endocrinol. Metab. 2010, 21:3-9.
14. Biddie S.C., John S., Sabo P.J., Thurman R.E., Johnson T.A., Schiltz R.L., Miranda T.B., Sung M.H., Trump S., Lightman S.L., Vinson C., Stamatoyannopoulos J.A., Hager G.L. Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding. Mol. Cell 2011, 43:145-155.
15. Bilodeau S., Vallette-Kasic S., Gauthier Y., Figarella-Branger D., Brue T., Berthelet F., Lacroix A., Batista D., Stratakis C., Hanson J., Meij B., Drouin J. Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease. Genes Dev. 2006, 20:2871-2886.
16. Birnbaum R.Y., Clowney E.J., Agamy O., Kim M.J., Zhao J., Yamanaka T., Pappalardo Z., Clarke S.L., Wenger A.M., Nguyen L., Gurrieri F., Everman D.B., Schwartz C.E., Birk O.S., Bejerano G., Lomvardas S., Ahituv N. Coding exons function as tissue-specific enhancers of nearby genes. Genome Res. 2012, 22:1059-1068.
17. Bledsoe R.K., Montana V.G., Stanley T.B., Delves C.J., Apolito C.J., McKee D.D., Consler T.G., Parks D.J., Stewart E.L., Willson T.M., Lambert M.H., Moore J.T., Pearce K.H., Xu H.E. Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell 2002, 110:93-105.
18. Boldin M.P., Baltimore D. MicroRNAs, new effectors and regulators of NF-kappaB. Immunol. Rev. 2012, 246:205-220.
19. Bougarne N., Paumelle R., Caron S., Hennuyer N., Mansouri R., Gervois P., Staels B., Haegeman G., De Bosscher K. PPARalpha blocks glucocorticoid receptor alpha-mediated transactivation but cooperates with the activated glucocorticoid receptor alpha for transrepression on NF-kappaB. Proc. Natl. Acad. Sci. USA 2009, 106:7397-7402.
20. Busillo J.M., Azzam K.M., Cidlowski J.A. Glucocorticoids sensitize the innate immune system through regulation of the NLRP3 inflammasome. J. Biol. Chem. 2011, 286:38703-38713.
21. Carroll J.S., Brown M. Estrogen receptor target gene: an evolving concept. Mol. Endocrinol. 2006, 20:1707-1714.
22. Choy M.K., Movassagh M., Goh H.G., Bennett M.R., Down T.A., Foo R.S. Genome-wide conserved consensus transcription factor binding motifs are hyper-methylated. BMC Genom. 2010, 11:519.
23. Clark A.R. Anti-inflammatory functions of glucocorticoid-induced genes. Mol. Cell Endocrinol. 2007, 275:79-97.
24. Coghlan M.J., Jacobson P.B., Lane B., Nakane M., Lin C.W., Elmore S.W., Kym P.R., Luly J.R., Carter G.W., Turner R., Tyree C.M., Hu J., Elgort M., Rosen J., Miner J.N. A novel antiinflammatory maintains glucocorticoid efficacy with reduced side effects. Mol. Endocrinol. 2003, 17:860-869.
25. Collison A., Mattes J., Plank M., Foster P.S. Inhibition of house dust mite-induced allergic airways disease by antagonism of microRNA-145 is comparable to glucocorticoid treatment. J. Allergy Clin. Immunol. 2011, 128(160-167):e4.
26. Conway-Campbell B.L., George C.L., Pooley J.R., Knight D.M., Norman M.R., Hager G.L., Lightman S.L. The HSP90 molecular chaperone cycle regulates cyclical transcriptional dynamics of the glucocorticoid receptor and its coregulatory molecules CBP/p300 during ultradian ligand treatment. Mol. Endocrinol. 2011, 25:944-954.
27. De Bosscher K. Selective glucocorticoid receptor modulators. J. Steroid Biochem. Mol. Biol. 2010, 120:96-104.
28. De Bosscher K., Vanden Berghe W., Haegeman G. The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. Endocr. Rev. 2003, 24:488-522.
29. De Bosscher K., Haegeman G., Elewaut D. Targeting inflammation using selective glucocorticoid receptor modulators. Curr. Opin. Pharmacol. 2010, 10:497-504.
30. de Lange P., Segeren C.M., Koper J.W., Wiemer E., Sonneveld P., Brinkmann A.O., White A., Brogan I.J., de Jong F.H., Lamberts S.W. Expression in hematological malignancies of a glucocorticoid receptor splice variant that augments glucocorticoid receptor-mediated effects in transfected cells. Cancer Res. 2001, 61:3937-3941.
31. De Martino M.U., Alesci S., Chrousos G.P., Kino T. Interaction of the glucocorticoid receptor and the chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII): implications for the actions of glucocorticoids on glucose, lipoprotein, and xenobiotic metabolism. Ann. NY Acad. Sci. 2004, 1024:72-85.
32. Delerive P., De Bosscher K., Besnard S., Vanden Berghe W., Peters J.M., Gonzalez F.J., Fruchart J.C., Tedgui A., Haegeman G., Staels B. Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. J. Biol. Chem. 1999, 274:32048-32054.
33. Diamond M.I., Miner J.N., Yoshinaga S.K., Yamamoto K.R. Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science 1990, 249:1266-1272.
34. Diaz-Gallardo M.Y., Cote-Velez A., Charli J.L., Joseph-Bravo P. A rapid interference between glucocorticoids and cAMP-activated signalling in hypothalamic neurones prevents binding of phosphorylated cAMP response element binding protein and glucocorticoid receptor at the CRE-Like and composite GRE sites of thyrotrophin-releasing hormone gene promoter. J. Neuroendocrinol. 2010, 22:282-293.
35. Diefenbacher M., Sekula S., Heilbock C., Maier J.V., Litfin M., van Dam H., Castellazzi M., Herrlich P., Kassel O. Restriction to Fos family members of Trip6-dependent coactivation and glucocorticoid receptor-dependent trans-repression of activator protein-1. Mol. Endocrinol. 2008, 22:1767-1780.
36. Diefenbacher M.E., Litfin M., Herrlich P., Kassel O. The nuclear isoform of the LIM domain protein Trip6 integrates activating and repressing signals at the promoter-bound glucocorticoid receptor. Mol. Cell Endocrinol. 2010, 320:58-66.
37. Duma D., Collins J.B., Chou J.W., Cidlowski J.A. Sexually dimorphic actions of glucocorticoids provide a link to inflammatory diseases with gender differences in prevalence. Sci. Signal. 2010, 3:ra74.
38. Engblom D., Kornfeld J.W., Schwake L., Tronche F., Reimann A., Beug H., Hennighausen L., Moriggl R., Schutz G. Direct glucocorticoid receptor-Stat5 interaction in hepatocytes controls body size and maturation-related gene expression. Genes Dev. 2007, 21:1157-1162.
39. Engel K.B., Yamamoto K.R. The glucocorticoid receptor and the coregulator Brm selectively modulate each other's occupancy and activity in a gene-specific manner. Mol. Cell Biol. 2011, 31:3267-3276.
40. Flammer J.R., Dobrovolna J., Kennedy M.A., Chinenov Y., Glass C.K., Ivashkiv L.B., Rogatsky I. The type I interferon signaling pathway is a target for glucocorticoid inhibition. Mol. Cell Biol. 2010, 30:4564-4574.
41. Flick M.B., Sapi E., Kacinski B.M. Hormonal regulation of the c-fms proto-oncogene in breast cancer cells is mediated by a composite glucocorticoid response element. J. Cell Biochem. 2002, 85:10-23.
42. Freeman B.C., Yamamoto K.R. Disassembly of transcriptional regulatory complexes by molecular chaperones. Science 2002, 296:2232-2235.
43. Galliher-Beckley A.J., Williams J.G., Cidlowski J.A. Ligand-independent phosphorylation of the glucocorticoid receptor integrates cellular stress pathways with nuclear receptor signaling. Mol. Cell Biol. 2011, 31:4663-4675.
44. Gathercole L.L., Morgan S.A., Bujalska I.J., Hauton D., Stewart P.M., Tomlinson J.W. Regulation of lipogenesis by glucocorticoids and insulin in human adipose tissue. PLoS One 2011, 6:e26223.
45. Gehani S.S., Agrawal-Singh S., Dietrich N., Christophersen N.S., Helin K., Hansen K. Polycomb group protein displacement and gene activation through MSK-dependent H3K27me3S28 phosphorylation. Mol. Cell 2010, 39:886-900.
46. George A.A., Schiltz R.L., Hager G.L. Dynamic access of the glucocorticoid receptor to response elements in chromatin. Int. J. Biochem. Cell Biol. 2009, 41:214-224.
47. Geserick C., Meyer H.A., Haendler B. The role of DNA response elements as allosteric modulators of steroid receptor function. Mol. Cell Endocrinol. 2005, 236:1-7.
48. Grad I., Picard D. The glucocorticoid responses are shaped by molecular chaperones. Mol. Cell Endocrinol. 2007, 275:2-12.
49. Groeneweg F.L., Karst H., de Kloet E.R., Joels M. Mineralocorticoid and glucocorticoid receptors at the neuronal membrane, regulators of nongenomic corticosteroid signalling. Mol. Cell Endocrinol. 2012, 350:299-309.
50. Gross K.L., Oakley R.H., Scoltock A.B., Jewell C.M., Cidlowski J.A. Glucocorticoid receptor alpha isoform-selective regulation of antiapoptotic genes in osteosarcoma cells: a new mechanism for glucocorticoid resistance. Mol. Endocrinol. 2011, 25:1087-1099.
51. Guiducci C., Gong M., Xu Z., Gill M., Chaussabel D., Meeker T., Chan J.H., Wright T., Punaro M., Bolland S., Soumelis V., Banchereau J., Coffman R.L., Pascual V., Barrat F.J. TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus. Nature 2010, 465:937-941.
52. Guo L., Lichten L.A., Ryu M.S., Liuzzi J.P., Wang F., Cousins R.J. STAT5-glucocorticoid receptor interaction and MTF-1 regulate the expression of ZnT2 (Slc30a2) in pancreatic acinar cells. Proc. Natl. Acad. Sci. USA 2010, 107:2818-2823.
53. Han Y., Staab-Weijnitz C.A., Xiong G., Maser E. Identification of microRNAs as a potential novel regulatory mechanism in HSD11B1 expression. J. Steroid Biochem. Mol. Biol. 2013, 133:129-139.
54. Hervouet E., Vallette F.M., Cartron P.F. Dnmt1/Transcription factor interactions: an alternative mechanism of DNA methylation inheritance. Genes Cancer 2010, 1:434-443.
55. Hoberg J.E., Popko A.E., Ramsey C.S., Mayo M.W. IkappaB kinase alpha-mediated derepression of SMRT potentiates acetylation of RelA/p65 by p300. Mol. Cell Biol. 2006, 26:457-471.
56. Hollenberg S.M., Evans R.M. Multiple and cooperative trans-activation domains of the human glucocorticoid receptor. Cell 1988, 55:899-906.
57. Hollenberg S.M., Giguere V., Segui P., Evans R.M. Colocalization of DNA-binding and transcriptional activation functions in the human glucocorticoid receptor. Cell 1987, 49:39-46.
58. Hollenberg S.M., Giguere V., Evans R.M. Identification of two regions of the human glucocorticoid receptor hormone binding domain that block activation. Cancer Res. 1989, 49:2292s-2294s.
59. Hudson W.H., Youn C., Ortlund E.A. The structural basis of direct glucocorticoid-mediated transrepression. Nat Struct Mol Biol. 2012, 90.
60. Icardi L., De Bosscher K., Tavernier J. The HAT/HDAC interplay: multilevel control of STAT signaling. Cytokine Growth Factor Rev. 2012.
61. Icardi L., Mori R., Gesellchen V., Eyckerman S., De Cauwer L., Verhelst J., Vercauteren K., Saelens X., Meuleman P., Leroux-Roels G., De Bosscher K., Boutros M., Tavernier J. The Sin3a repressor complex is a master regulator of STAT transcriptional activity. Proc. Natl. Acad. Sci. USA 2012, 109:12058-12063.
62. Ito K., Barnes P.J., Adcock I.M. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol. Cell Biol. 2000, 20:6891-6903.
63. Ito K., Lim S., Caramori G., Cosio B., Chung K.F., Adcock I.M., Barnes P.J. A molecular mechanism of action of theophylline: induction of histone deacetylase activity to decrease inflammatory gene expression. Proc. Natl. Acad. Sci. USA 2002, 99:8921-8926.
64. Ito K., Yamamura S., Essilfie-Quaye S., Cosio B., Ito M., Barnes P.J., Adcock I.M. Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression. J. Exp. Med. 2006, 203:7-13.
65. Jewell C.M., Scoltock A.B., Hamel B.L., Yudt M.R., Cidlowski J.A. Complex human glucocorticoid receptor dim mutations define glucocorticoid induced apoptotic resistance in bone cells. Mol. Endocrinol. 2012, 26:244-256.
66. John S., Sabo P.J., Thurman R.E., Sung M.H., Biddie S.C., Johnson T.A., Hager G.L., Stamatoyannopoulos J.A. Chromatin accessibility pre-determines glucocorticoid receptor binding patterns. Nat. Genet. 2011, 43:264-268.
67. Kabotyanski E.B., Huetter M., Xian W., Rijnkels M., Rosen J.M. Integration of prolactin and glucocorticoid signaling at the beta-casein promoter and enhancer by ordered recruitment of specific transcription factors and chromatin modifiers. Mol. Endocrinol. 2006, 20:2355-2368.
68. Kabotyanski E.B., Rijnkels M., Freeman-Zadrowski C., Buser A.C., Edwards D.P., Rosen J.M. Lactogenic hormonal induction of long distance interactions between beta-casein gene regulatory elements. J. Biol. Chem. 2009, 284:22815-22824.
69. Karagianni N., Tsawdaroglou N. The c-fos serum response element (SRE) confers negative response to glucocorticoids. Oncogene 1994, 9:2327-2334.
70. Kassel O., Herrlich P. Crosstalk between the glucocorticoid receptor and other transcription factors: molecular aspects. Mol. Cell Endocrinol. 2007, 275:13-29.
71. Kassel O., Schneider S., Heilbock C., Litfin M., Gottlicher M., Herrlich P. A nuclear isoform of the focal adhesion LIM-domain protein Trip6 integrates activating and repressing signals at AP-1- and NF-kappaB-regulated promoters. Genes Dev. 2004, 18:2518-2528.
72. Ki S.H., Cho I.J., Choi D.W., Kim S.G. Glucocorticoid receptor (GR)-associated SMRT binding to C/EBPbeta TAD and Nrf2 Neh4/5: role of SMRT recruited to GR in GSTA2 gene repression. Mol. Cell Biol. 2005, 25:4150-4165.
73. King H.A., Trotter K.W., Archer T.K. Chromatin remodeling during glucocorticoid receptor regulated transactivation. Biochim. Biophys. Acta 2012, 1819:716-726.
74. Kleiman A., Tuckermann J.P. Glucocorticoid receptor action in beneficial and side effects of steroid therapy: lessons from conditional knockout mice. Mol. Cell Endocrinol. 2007, 275:98-108.
75. Kleiman A., Hubner S., Rodriguez Parkitna J.M., Neumann A., Hofer S., Weigand M.A., Bauer M., Schmid W., Schutz G., Libert C., Reichardt H.M., Tuckermann J.P. Glucocorticoid receptor dimerization is required for survival in septic shock via suppression of interleukin-1 in macrophages. FASEB J. 2012, 26:722-729.
76. Klinge C.M., Jernigan S.C., Smith S.L., Tyulmenkov V.V., Kulakosky P.C. Estrogen response element sequence impacts the conformation and transcriptional activity of estrogen receptor alpha. Mol. Cell Endocrinol. 2001, 174:151-166.
77. Kovacs J.J., Murphy P.J., Gaillard S., Zhao X., Wu J.T., Nicchitta C.V., Yoshida M., Toft D.O., Pratt W.B., Yao T.P. HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. Mol. Cell 2005, 18:601-607.
78. Kumar R., Thompson E.B. Gene regulation by the glucocorticoid receptor: structure:function relationship. J. Steroid Biochem. Mol. Biol. 2005, 94:383-394.
79. Langlais D., Couture C., Balsalobre A., Drouin J. The Stat3/GR interaction code: predictive value of direct/indirect DNA recruitment for transcription outcome. Mol. Cell 2012, 47:38-49.
80. Lannan E.A., Galliher-Beckley A.J., Scoltock A.B., Cidlowski J.A. Proinflammatory actions of glucocorticoids: glucocorticoids and TNFalpha coregulate gene expression in vitro and in vivo. Endocrinology 2012, 153:3701-3712.
81. Latchoumanin O., Mynard V., Devin-Leclerc J., Dugue M.A., Bertagna X., Catelli M.G. Reversal of glucocorticoids-dependent proopiomelanocortin gene inhibition by leukemia inhibitory factor. Endocrinology 2007, 148:422-432.
82. Lechner J., Welte T., Doppler W. Mechanism of interaction between the glucocorticoid receptor and Stat5: role of DNA-binding. Immunobiology 1997, 198:112-123.
83. Lechner J., Welte T., Tomasi J.K., Bruno P., Cairns C., Gustafsson J., Doppler W. Promoter-dependent synergy between glucocorticoid receptor and Stat5 in the activation of beta-casein gene transcription. J. Biol. Chem. 1997, 272:20954-20960.
84. Ledderose C., Möhnle P., Limbeck E., Schütz S., Weis F., Rink J., Briegel J., Kreth S. Corticosteroid resistance in sepsis is influenced by microRNA-124-induced downregulation of glucocorticoid receptor-α. Crit Care Med. 2012, 40:2745-2753.
85. Lefstin J.A., Yamamoto K.R. Allosteric effects of DNA on transcriptional regulators. Nature 1998, 392:885-888.
86. Lefstin J.A., Thomas J.R., Yamamoto K.R. Influence of a steroid receptor DNA-binding domain on transcriptional regulatory functions. Genes Dev. 1994, 8:2842-2856.
87. Lerner L., Henriksen M.A., Zhang X., Darnell J.E. STAT3-dependent enhanceosome assembly and disassembly: synergy with GR for full transcriptional increase of the alpha 2-macroglobulin gene. Genes Dev. 2003, 17:2564-2577.
88. Li R., Guo W., Gu J., Zhang M.Q., Wang X. Chromatin state and microRNA determine different gene expression dynamics responsive to TNF stimulation. Genomics 2012.
89. Liberman A.C., Refojo D., Druker J., Toscano M., Rein T., Holsboer F., Arzt E. The activated glucocorticoid receptor inhibits the transcription factor T-bet by direct protein-protein interaction. FASEB J. 2007, 21:1177-1188.
90. Liberman A.C., Druker J., Garcia F.A., Holsboer F., Arzt E. Intracellular molecular signaling. Basis for specificity to glucocorticoid anti-inflammatory actions. Ann. NY Acad. Sci. 2009, 1153:6-13.
91. Liberman A.C., Druker J., Refojo D., Holsboer F., Arzt E. Glucocorticoids inhibit GATA-3 phosphorylation and activity in T cells. FASEB J. 2009, 23:1558-1571.
92. Liden J., Delaunay F., Rafter I., Gustafsson J., Okret S. A new function for the C-terminal zinc finger of the glucocorticoid receptor. Repression of RelA transactivation. J. Biol. Chem. 1997, 272:21467-21472.
93. Lieberman-Aiden E., van Berkum N.L., Williams L., Imakaev M., Ragoczy T., Telling A., Amit I., Lajoie B.R., Sabo P.J., Dorschner M.O., Sandstrom R., Bernstein B., Bender M.A., Groudine M., Gnirke A., Stamatoyannopoulos J., Mirny L.A., Lander E.S., Dekker J. Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science 2009, 326:289-293.
94. Lowenberg M., Verhaar A.P., van den Brink G.R., Hommes D.W. Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression. Trends Mol. Med. 2007, 13:158-163.
95. Lu N.Z., Cidlowski J.A. Glucocorticoid receptor isoforms generate transcription specificity. Trends Cell Biol. 2006, 16:301-307.
96. Lu N.Z., Collins J.B., Grissom S.F., Cidlowski J.A. Selective regulation of bone cell apoptosis by translational isoforms of the glucocorticoid receptor. Mol. Cell Biol. 2007, 27:7143-7160.
97. Lu S., Mukkada V.A., Mangray S., Cleveland K., Shillingford N., Schorl C., Brodsky A.S., Resnick M.B. MicroRNA profiling in mucosal biopsies of eosinophilic esophagitis patients pre and post treatment with steroids and relationship with mRNA targets. PLoS One 2012, 7:e40676.
98. Luecke H.F., Yamamoto K.R. The glucocorticoid receptor blocks P-TEFb recruitment by NFkappaB to effect promoter-specific transcriptional repression. Genes Dev. 2005, 19:1116-1127.
99. Malkoski S.P., Dorin R.I. Composite glucocorticoid regulation at a functionally defined negative glucocorticoid response element of the human corticotropin-releasing hormone gene. Mol. Endocrinol. 1999, 13:1629-1644.
100. Meijsing S.H., Pufall M.A., So A.Y., Bates D.L., Chen L., Yamamoto K.R. DNA binding site sequence directs glucocorticoid receptor structure and activity. Science 2009, 324:407-410.
101. Molitoris J.K., McColl K.S., Distelhorst C.W. Glucocorticoid-mediated repression of the oncogenic microRNA cluster miR-17~92 contributes to the induction of Bim and initiation of apoptosis. Mol. Endocrinol. 2011, 25:409-420.
102. Newton R., Holden N.S. Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor?. Mol. Pharmacol. 2007, 72:799-809.
103. Nielsen R., Pedersen T.A., Hagenbeek D., Moulos P., Siersbaek R., Megens E., Denissov S., Borgesen M., Francoijs K.J., Mandrup S., Stunnenberg H.G. Genome-wide profiling of PPARgamma:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis. Genes Dev. 2008, 22:2953-2967.
104. Nissen R.M., Yamamoto K.R. The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev. 2000, 14:2314-2329.
105. Nogami H., Hiraoka Y., Matsubara M., Nonobe E., Harigaya T., Katayama M., Hemmi N., Kobayashi S., Mogi K., Aiso S., Kawamura K., Hisano S. A composite hormone response element regulates transcription of the rat GHRH receptor gene. Endocrinology 2002, 143:1318-1326.
106. Oakley R.H., Cidlowski J.A. Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids. J. Biol. Chem. 2011, 286:3177-3184.
107. Oakley R.H., Sar M., Cidlowski J.A. The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function. J. Biol. Chem. 1996, 271:9550-9559.
108. Ogawa S., Lozach J., Jepsen K., Sawka-Verhelle D., Perissi V., Sasik R., Rose D.W., Johnson R.S., Rosenfeld M.G., Glass C.K. A nuclear receptor corepressor transcriptional checkpoint controlling activator protein 1-dependent gene networks required for macrophage activation. Proc. Natl. Acad. Sci. USA 2004, 101:14461-14466.
109. Ogawa S., Lozach J., Benner C., Pascual G., Tangirala R.K., Westin S., Hoffmann A., Subramaniam S., David M., Rosenfeld M.G., Glass C.K. Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell 2005, 122:707-721.
110. Pan D., Kocherginsky M., Conzen S.D. Activation of the glucocorticoid receptor is associated with poor prognosis in estrogen receptor-negative breast cancer. Cancer Res. 2011, 71:6360-6370.
111. Pearce D., Matsui W., Miner J.N., Yamamoto K.R. Glucocorticoid receptor transcriptional activity determined by spacing of receptor and nonreceptor DNA sites. J. Biol. Chem. 1998, 273:30081-30085.
112. Price D.H. P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol. Cell Biol. 2000, 20:2629-2634.
113. Rao N.A., McCalman M.T., Moulos P., Francoijs K.J., Chatziioannou A., Kolisis F.N., Alexis M.N., Mitsiou D.J., Stunnenberg H.G. Coactivation of GR and NFKB alters the repertoire of their binding sites and target genes. Genome Res. 2011, 21:1404-1416.
114. Rauch A., Seitz S., Baschant U., Schilling A.F., Illing A., Stride B., Kirilov M., Mandic V., Takacz A., Schmidt-Ullrich R., Ostermay S., Schinke T., Spanbroek R., Zaiss M.M., Angel P.E., Lerner U.H., David J.P., Reichardt H.M., Amling M., Schutz G., Tuckermann J.P. Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor. Cell Metab. 2010, 11:517-531.
115. Rauch A., Gossye V., Bracke D., Gevaert E., Jacques P., Van Beneden K., Vandooren B., Rauner M., Hofbauer L.C., Haegeman G., Elewaut D., Tuckermann J.P., De Bosscher K. An anti-inflammatory selective glucocorticoid receptor modulator preserves osteoblast differentiation. FASEB J. 2011, 25:1323-1332.
116. Rauner M., Goettsch C., Stein N., Thiele S., Bornhaeuser M., De Bosscher K., Haegeman G., Tuckermann J., Hofbauer L.C. Dissociation of osteogenic and immunological effects by the selective glucocorticoid receptor agonist, compound A, in human bone marrow stromal cells. Endocrinology 2011, 152:103-112.
117. Ray A., LaForge S., Sehgal P.B. Repressor to activator switch by mutation in the first Zn finger of the glucocorticoid receptor: Is direct DNA binding necessary?. Proc. Natl. Acad. Sci.USA 1991, 88:7086-7090.
118. Reddy T.E., Pauli F., Sprouse R.O., Neff N.F., Newberry K.M., Garabedian M.J., Myers R.M. Genomic determination of the glucocorticoid response reveals unexpected mechanisms of gene regulation. Genome Res. 2009, 19:2163-2171.
119. Reichardt H.M., Kaestner K.H., Tuckermann J., Kretz O., Wessely O., Bock R., Gass P., Schmid W., Herrlich P., Angel P., Schütz G. DNA binding of the glucocorticoid receptor is not essential for survival. Cell 1998, 93:531-541.
120. Reily M.M., Pantoja C., Hu X., Chinenov Y., Rogatsky I. The GRIP1:IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppression. EMBO J. 2006, 25:108-117.
121. Ricote M., Li A.C., Willson T.M., Kelly C.J., Glass C.K. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998, 391:79-86.
122. Rivers C., Levy A., Hancock J., Lightman S., Norman M. Insertion of an amino acid in the DNA-binding domain of the glucocorticoid receptor as a result of alternative splicing. J. Clin. Endocrinol. Metab. 1999, 84:4283-4286.
123. Rogatsky I., Luecke H.F., Leitman D.C., Yamamoto K.R. Alternate surfaces of transcriptional coregulator GRIP1 function in different glucocorticoid receptor activation and repression contexts. Proc. Natl. Acad. Sci. USA 2002, 99:16701-16706.
124. Ronacher K., Hadley K., Avenant C., Stubsrud E., Simons S.S., Louw A., Hapgood J.P. Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction. Mol. Cell Endocrinol. 2009, 299:219-231.
125. Sakai D.D., Helms S., Carlstedt-Duke J., Gustafsson J.A., Rottman F.M., Yamamoto K.R. Hormone-mediated repression: a negative glucocorticoid response element from the bovine prolactin gene. Genes Dev. 1988, 2:1144-1154.
126. Schaaf M.J., Cidlowski J.A. Molecular mechanisms of glucocorticoid action and resistance. J. Steroid Biochem. Mol. Biol. 2002, 83:37-48.
127. Schäcke H., Docke W.D., Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol. Ther. 2002, 96:23-43.
128. Schäcke H., Zollner T., Docke W., Rehwinkel H., Jaroch S., Skuballa W., Neuhaus R., May E., Zugel U., Asadullah K. Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases. Br. J. Pharmacol. 2009, 158:1088-1103.
129. Shimizu N., Yoshikawa N., Ito N., Maruyama T., Suzuki Y., Takeda S., Nakae J., Tagata Y., Nishitani S., Takehana K., Sano M., Fukuda K., Suematsu M., Morimoto C., Tanaka H. Crosstalk between glucocorticoid receptor and nutritional sensor mTOR in skeletal muscle. Cell Metab. 2011, 13:170-182.
130. Siersbaek R., Mandrup S. Transcriptional networks controlling adipocyte differentiation. Cold Spring Harb. Symp. Quant. Biol. 2011, 76:247-255.
131. Silverman M.N., Sternberg E.M. Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction. Ann. NY Acad. Sci. 2012, 1261:55-63.
132. Smith L.K., Shah R.R., Cidlowski J.A. Glucocorticoids modulate microRNA expression and processing during lymphocyte apoptosis. J. Biol. Chem. 2010, 285:36698-36708.
133. So A.Y., Chaivorapol C., Bolton E.C., Li H., Yamamoto K.R. Determinants of cell- and gene-specific transcriptional regulation by the glucocorticoid receptor. PLoS Genet. 2007, 3:e94.
134. So A.Y., Cooper S.B., Feldman B.J., Manuchehri M., Yamamoto K.R. Conservation analysis predicts in vivo occupancy of glucocorticoid receptor-binding sequences at glucocorticoid-induced genes. Proc. Natl. Acad. Sci. USA 2008, 105:5745-5749.
135. Song I.H., Buttgereit F. Non-genomic glucocorticoid effects to provide the basis for new drug developments. Mol. Cell Endocrinol. 2006, 246:142-146.
136. Staels B., Koenig W., Habib A., Merval R., Lebret M., Torra I.P., Delerive P., Fadel A., Chinetti G., Fruchart J.C., Najib J., Maclouf J., Tedgui A. Activation of human aortic smooth-muscle cells is inhibited by PPARalfa but not by PPARgamma activators. Nature 1998, 393:790-793.
137. Stöcklin E., Wissler M., Gouilleux F., Groner B. Functional interactions between stat5 and the glucocorticoid receptor. Nature 1996, 383:726-728.
138. Stöcklin E., Wissler M., Moriggl R., Groner B. Specific DNA binding of Stat5, but not of glucocorticoid receptor, is required for their functional cooperation in the regulation of gene transcription. Mol. Cell Biol. 1997, 17:6708-6716.
139. Stoecklin E., Wissler M., Schaetzle D., Pfitzner E., Groner B. Interactions in the transcriptional regulation exerted by Stat5 and by members of the steroid hormone receptor family. J. Steroid Biochem. Mol. Biol. 1999, 69:195-204.
140. Strehl C., Gaber T., Lowenberg M., Hommes D.W., Verhaar A.P., Schellmann S., Hahne M., Fangradt M., Wagegg M., Hoff P., Scheffold A., Spies C.M., Burmester G.R., Buttgereit F. Origin and functional activity of the membrane-bound glucocorticoid receptor. Arthritis Rheum. 2011, 63:3779-3788.
141. Stromstedt P.E., Poellinger L., Gustafsson J.A., Carlstedt-Duke J. The glucocorticoid receptor binds to a sequence overlapping the TATA box of the human osteocalcin promoter: a potential mechanism for negative regulation. Mol. Cell Biol. 1991, 11:3379-3383.
142. Subramaniam N., Cairns W., Okret S. Glucocorticoids repress transcription from a negative glucocorticoid response element recognized by two homeodomain-containing proteins, Pbx and Oct-1. J. Biol. Chem. 1998, 273:23567-23574.
143. Surjit M., Ganti K.P., Mukherji A., Ye T., Hua G., Metzger D., Li M., Chambon P. Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor. Cell 2011, 145:224-241.
144. Tao Y., Williams-Skipp C., Scheinman R.I. Mapping of glucocorticoid receptor DNA binding domain surfaces contributing to transrepression of NF-kappa B and induction of apoptosis. J. Biol. Chem. 2001, 276:2329-2332.
145. Tessel M.A., Benham A.L., Krett N.L., Rosen S.T., Gunaratne P.H. Role for microRNAs in regulating glucocorticoid response and resistance in multiple myeloma. Horm Cancer. 2011, 2:182-189.
146. Thiele S., Ziegler N., Tsourdi E., De Bosscher K., Tuckermann J.P., Hofbauer L.C., Rauner M. Selective glucocorticoid receptor modulation maintains bone mineral density in mice. J. Bone Miner. Res. 2012.
147. Tiwari V.K., Stadler M.B., Wirbelauer C., Paro R., Schubeler D., Beisel C. A chromatin-modifying function of JNK during stem cell differentiation. Nat. Genet. 2012, 44:94-100.
148. Tuckermann J.P., Kleiman A., Moriggl R., Spanbroek R., Neumann A., Illing A., Clausen B.E., Stride B., Forster I., Habenicht A.J., Reichardt H.M., Tronche F., Schmid W., Schutz G. Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy. J. Clin. Invest. 2007, 117:1381-1390.
149. Van Bogaert T., De Bosscher K., Libert C. Crosstalk between TNF and glucocorticoid receptor signaling pathways. Cytokine Growth Factor Rev. 2010, 21:275-286.
150. Van Bogaert T., Vandevyver S., Dejager L., Van Hauwermeiren F., Pinheiro I., Petta I., Engblom D., Kleyman A., Schutz G., Tuckermann J., Libert C. Tumor necrosis factor inhibits glucocorticoid receptor function in mice: a strong signal toward lethal shock. J. Biol. Chem. 2011, 286:26555-26567.
151. van Raalte D.H., Ouwens D.M., Diamant M. Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options?. Eur. J. Clin. Invest. 2009, 39:81-93.
152. van Tilborg M.A., Lefstin J.A., Kruiskamp M., Teuben J., Boelens R., Yamamoto K.R., Kaptein R. Mutations in the glucocorticoid receptor DNA-binding domain mimic an allosteric effect of DNA. J. Mol. Biol. 2000, 301:947-958.
153. Vandevyver S., Dejager L., Libert C. On the trail of the glucocorticoid receptor: into the nucleus and back. Traffic 2012, 13:364-374.
154. Vandevyver S., Dejager L., Van Bogaert T., Kleyman A., Liu Y., Tuckermann J., Libert C. Glucocorticoid receptor dimerization induces MKP1 to protect against TNF-induced inflammation. J. Clin. Invest. 2012, 122:2130-2140.
155. Vinson G.P. The mislabelling of deoxycorticosterone: making sense of corticosteroid structure and function. J. Endocrinol. 2011, 211:3-16.
156. Vreugdenhil E., Verissimo C.S., Mariman R., Kamphorst J.T., Barbosa J.S., Zweers T., Champagne D.L., Schouten T., Meijer O.C., de Kloet E.R., Fitzsimons C.P. MicroRNA 18 and 124a down-regulate the glucocorticoid receptor: implications for glucocorticoid responsiveness in the brain. Endocrinology 2009, 150:2220-2228.
157. Wang W., Li J.J., Foster P.S., Hansbro P.M., Yang M. Potential therapeutic targets for steroid-resistant asthma. Curr. Drug Targets 2010, 11:957-970.
158. Weiss C., Schneider S., Wagner E.F., Zhang X., Seto E., Bohmann D. JNK phosphorylation relieves HDAC3-dependent suppression of the transcriptional activity of c-Jun. EMBO J. 2003, 22:3686-3695.
159. Welboren W.J., van Driel M.A., Janssen-Megens E.M., van Heeringen S.J., Sweep F.C., Span P.N., Stunnenberg H.G. ChIP-Seq of ERalpha and RNA polymerase II defines genes differentially responding to ligands. EMBO J. 2009, 28:1418-1428.
160. Wiench M., John S., Baek S., Johnson T.A., Sung M.H., Escobar T., Simmons C.A., Pearce K.H., Biddie S.C., Sabo P.J., Thurman R.E., Stamatoyannopoulos J.A., Hager G.L. DNA methylation status predicts cell type-specific enhancer activity. EMBO J. 2011, 30:3028-3039.
161. Wiklund E.D., Kjems J., Clark S.J. Epigenetic architecture and miRNA: reciprocal regulators. Epigenomics 2010, 2:823-840.
162. Williams A.E., Larner-Svensson H., Perry M.M., Campbell G.A., Herrick S.E., Adcock I.M., Erjefalt J.S., Chung K.F., Lindsay M.A. MicroRNA expression profiling in mild asthmatic human airways and effect of corticosteroid therapy. PLoS One 2009, 4:e5889.
163. Wissink S., van Heerde E.C., Schmitz M.L., Kalkhoven E., van der Burg B., Baeuerle P.A., van der Saag P.T. Distinct domains of the RelA NF-kappaB subunit are required for negative cross-talk and direct interaction with the glucocorticoid receptor. J. Biol. Chem. 1997, 272:22278-22284.
164. Wright A.P., Zilliacus J., McEwan I.J., Dahlman Wright K., Almlof T., Carlstedt Duke J., Gustafsson J.A. Structure and function of the glucocorticoid receptor. J. Steroid Biochem. Mol. Biol. 1993, 47:11-19.
165. Wu J., Bresnick E.H. Glucocorticoid and growth factor synergism requirement for Notch4 chromatin domain activation. Mol. Cell Biol. 2007, 27:2411-2422.
166. Wu J., Li Y., Dietz J., Lala D.S. Repression of p65 transcriptional activation by the glucocorticoid receptor in the absence of receptor-coactivator interactions. Mol. Endocrinol. 2004, 18:53-62.
167. Yamagata K., Fujiyama S., Ito S., Ueda T., Murata T., Naitou M., Takeyama K., Minami Y., O'Malley B.W., Kato S. Maturation of microRNA is hormonally regulated by a nuclear receptor. Mol. Cell 2009, 36:340-347.
168. Yu C.Y., Mayba O., Lee J.V., Tran J., Harris C., Speed T.P., Wang J.C. Genome-wide analysis of glucocorticoid receptor binding regions in adipocytes reveal gene network involved in triglyceride homeostasis. PLoS One 2010, 5:e15188.
169. Zheng Y., Xiong S., Jiang P., Liu R., Liu X., Qian J., Zheng X., Chu Y. Glucocorticoids inhibit lipopolysaccharide-mediated inflammatory response by downregulating microRNA-155: a novel anti-inflammation mechanism. Free Radic Biol Med. 2012, 52:1307-1317.